There are some new entrepreneurs on the block - and they are running "accelerators"
In February, NESTA issued a call for proposals to build further evidence on high-growth firms.
Medtech investing is tough - it's tough technically, regulatorily and commercially.
Follow our daily updates on Twitter @nesta_uk
Take part in the discussion on our LinkedIn group
Share your views on our Facebook page
Sign up for our regular updates for the latest news and opportunities.